1. The study will address whether medical marijuana can serve as an effective alternative to opioids for pain relief.
2. Research will be funded by Franklin BioScience, a cannabis grower and retailer planning on opening a medical marijuana dispensary in Bristol, Penn. this March.
3. Ari Greis, DO, a pain management specialist at Rothman, will oversee the research. “We’re all being cautiously optimistic that it could be helpful to some of our patients. Because we’re leaders in orthopedic medicine, we feel this is an opportunity we can’t pass up,” he said.
4. Patients with lower back and leg pain caused by sciatica are the target enrollment group for the observational study, as opioids are a common treatment for the condition.
5. The length of the study and number of patients involved are yet to be determined.
6. Last year, Children’s Hospital of Philadelphia announced a partnership to study the use of cannabis on children with autism.
More articles on anesthesia:
Iowa physician’s license to practice indefinitely suspended for providing inappropriate pain management: 6 things to know
Anesthesiologist Dr. Sean Kiley elected to allopathic medical honor society — 3 insights
Non-opioid pain treatment market to hit $22.6B by 2022 — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.